Skip to main content

What the FDA labels say about taking them together

Fosamprenavir and pimozide

Fosamprenavir's FDA label of September 15, 2023 names pimozide in its contraindications section; the pimozide label PlainMeds reads does not name fosamprenavir. The fosamprenavir label: “Coadministration is contraindicated due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias.”

Check it at the source: the fosamprenavir FDA label on DailyMed (effective September 15, 2023, Mylan Pharmaceuticals Inc.); the pimozide FDA label on DailyMed (effective August 12, 2026, Par Health USA, LLC).

What does the fosamprenavir label say about pimozide?

Fosamprenavir label, contraindications

Rifampin o Antipsychotic: Lurasidone (with ritonavir ), pimozide o Ergot derivatives: Dihydroergotamine, ergonovine, ergotamine, methylergonovine o GI motility agent:

Fosamprenavir label, drug interactions

Concomitant Drug Class/Drug Name: Pimozide; Effect on Concentration of Amprenavir or Concomitant Drug: ↑ Pimozide; Clinical Comment: Coadministration is contraindicated due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias [see ].

Source: FDA drug label (Fosamprenavir Calcium), Mylan Pharmaceuticals Inc., effective September 15, 2023 (SPL set 3a1424d8-844c-4e24-9ebd-b2c2b61b61a3), via openFDA; the full label on DailyMed

What does the pimozide label say about fosamprenavir?

Pimozide's label (effective August 12, 2026) does not name fosamprenavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Pimozide), Par Health USA, LLC, effective August 12, 2026 (SPL set 70b079e2-a1f7-4a93-8685-d60a4d7c1280), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

2Fosamprenavir generic labelers
2Pimozide generic labelers
FosamprenavirPimozide
Labeled forHIVn/a
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$1.23 per tablet 1 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?